Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market Report 2026

Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market Overview

• Artificial Intelligence (AI)-Assisted Variant Reinterpretation market size has reached to $1.76 billion in 2025 • Expected to grow to $4.76 billion in 2030 at a compound annual growth rate (CAGR) of 22.1% • Growth Driver: Growing Demand For Personalized Medicine Driving The Market Growth Due To Advances In Genomic Technologies And Molecular Diagnostics • Market Trend: AI-Powered Variant Ranking Systems Revolutionize Genetic Interpretation And Diagnostic Accuracy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market?

Artificial intelligence (AI)-assisted variant reinterpretation refers to the use of AI technologies to analyze and re-evaluate genetic variants in light of new scientific evidence, clinical data, or updated guidelines. This process helps clinicians and researchers update the classification of variants, improving diagnostic accuracy and guiding patient care decisions. The main components of artificial intelligence (AI)-assisted variant reinterpretation include software and services. Software refers to advanced analytical platforms that leverage algorithms and computational models to continuously reassess genetic variants and improve classification accuracy. These solutions are developed using machine learning, deep learning and neural networks, and natural language processing technologies and are deployed through cloud-based and on-premises models. The various applications involved are clinical diagnostics, research, drug development, personalized medicine, and other applications, and they are used by several end users such as hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end-users.

What Is The Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market Growth Forecast?

The artificial intelligence (AI)-assisted variant reinterpretation market size is expected to see exponential growth in the next few years. It will grow to $4.76 billion in 2030 at a compound annual growth rate (CAGR) of 22.1%. The growth in the forecast period can be attributed to growing integration of machine learning and deep learning platforms, increasing adoption of natural language processing for literature review, rising demand for cloud-based deployment, expansion of AI-assisted drug development, increasing focus on real-time variant monitoring and reinterpretation. Major trends in the forecast period include increasing adoption of cloud-based variant reinterpretation platforms, rising demand for ai-enabled clinical decision support, growing integration with electronic health records (ehr), expansion of real-time data annotation and labeling tools, rising focus on personalized medicine and patient-centric diagnostics.

Global Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market Segmentation

1) By Component: Software, Services 2) By Technology: Machine Learning, Deep Learning And Neural Networks, Natural Language Processing 3) By Deployment Mode: Cloud-Based, On-Premises 4) By Application: Clinical Diagnostics, Research, Drug Development, Personalized Medicine, Other Applications 5) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End-Users Subsegments: 1) By Software: Machine Learning Platforms, Natural Language Processing Platforms, Computer Vision Platforms, Speech Recognition Platforms, Data Labeling And Annotation Tools, Model Training And Development Tools, Model Deployment And Monitoring Tools, Decision Support Systems 2) By Services: Professional Services, Managed Services, Consulting Services, Integration And Implementation Services, Support And Maintenance Services, Training And Education Services

What Is The Driver Of The Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market?

The growing demand for personalized medicine is expected to drive the growth of the artificial intelligence (AI)-assisted variant reinterpretation market over the forecast period. Personalized medicine involves tailoring medical treatments and therapies to individual patients based on their genetic profiles, biomarkers, and disease characteristics. This demand is increasing due to advances in genomic sequencing technologies and molecular diagnostics, which enable more precise identification of genetic variants and support individualized treatment decisions that improve clinical outcomes. AI-assisted variant reinterpretation plays a critical role in personalized medicine by efficiently analyzing and reanalyzing genetic variants as new clinical evidence emerges. These solutions help clinicians and researchers generate accurate, patient-specific insights for diagnosis, treatment selection, and risk assessment, while reducing the time and complexity associated with manual variant interpretation. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the artificial intelligence (AI)-assisted variant reinterpretation industry.

Key Players In The Global Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market

Major companies operating in the artificial intelligence (AI)-assisted variant reinterpretation market are Illumina Inc., Tempus Labs Inc., Invitae Corporation, MedGenome Labs Private Limited, SOPHiA GENETICS S.A., Genomenon Inc., DNAnexus Inc., Alstronix Technologies Pvt Ltd, Lifebit Genomics Ltd, Strand Life Sciences Private Limited, Galatea Bio Inc., Clear Labs Inc., Congenica Ltd, Epigene Labs Pvt Ltd, Genoox Ltd, Breakthrough Genomics Inc., Genix.ai Inc., Nostos Genomics Inc., Variant Bio Inc., SeqOne Systems S.A.

Global Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market Trends and Insights

Major companies operating in the artificial intelligence (AI)-assisted variant reinterpretation market are increasingly focusing on developing innovative solutions such as explainable AI–powered variant ranking systems to streamline genetic variant interpretation and improve diagnostic accuracy. An AI-powered variant ranking system is a machine-learning–based tool that automatically scores and prioritizes genetic variants according to their likelihood of pathogenicity, enabling clinicians and geneticists to focus on the most clinically relevant findings. For instance, in October 2024, SeqOne S.A.S., a France-based AI-driven genomic software company, launched the DiagAI Score, an explainable AI–powered metric that evaluates and ranks genetic variants on a 0–100 scale based on pathogenicity, phenotype relevance, inheritance patterns, and data quality criteria. The solution integrates advanced components such as the Universal Pathogenicity Predictor (UP²) and Phenogenius to generate clinically meaningful scores while maintaining human expert oversight.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market?

In May 2025, GeneDx Holdings Corp., a US-based healthcare technology company, acquired Fabric Genomics for an undisclosed amount. With this acquisition, GeneDx aims to accelerate its transition into the next phase of genomic medicine by combining its extensive rare disease testing capabilities with AI driven genomic interpretation to expand decentralized testing, enhance diagnostic accuracy, and grow its global market reach. Fabric Genomics Inc. is a US-based healthcare technology company that specializes in providing artificial Intelligence (AI)-assisted variant reinterpretation and analysis through its fabric enterprise platform, which includes the fabric gem AI algorithm.

Regional Insights

North America was the largest region in the artificial intelligence (AI)-assisted variant reinterpretation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market?

The artificial intelligence (AI)-assisted variant reinterpretation market includes revenues earned by entities by providing services such as genetic variant classification, automated pathogenicity prediction, clinical report generation, data integration and annotation, and reinterpretation updates. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Artificial Intelligence (AI)-Assisted Variant Reinterpretation Market Report 2026?

The artificial intelligence (ai)-assisted variant reinterpretation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-assisted variant reinterpretation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.